This white paper offers guidance on implementing remote ratings for studies operating during the COVID-19 crisis.
Signant's experts discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty.
Learn about the important considerations regarding legal and regulatory needs, operations, clinical requirements, logistics, safety, and engagement.
